Daphne Koller, PhD

Founder and CEO · insitro

Pharma & Life SciencesNorth AmericaLarge following

Why follow Daphne

Explores how advanced machine learning can transform drug discovery and clinical development, sharing key updates on predictive biology and therapeutic design.

Writes about

Machine LearningDrug DiscoveryComputational Biology

Best for

AI researchers and computer-aided drug discovery specialists